- Advanced search
- Immuno Portal
- Malaria Portal
Molecular properties generated using the CDK
|Compound class||Synthetic organic|
|The monohydrochloride is described in the article , which provides the IUPAC name, 2-(adamantan-1-yl)-N-[2-methyl-5-(9-oxa-3,7-diazabicyclo[3.3.1]non-3-ylcarbonyl)phenyl]acetamide monohydrochloride, for this compound. We represent the molecule here, without the hydrochloride. AZ11657312 is an antagonist of the purinergic receptor 2X, ligand-gated ion channel 7 (P2X7) which is implicated the molecular mechanisms underlying pain and inflammation, as its activation leads to the release of proinflammatory cytokines such as interleukin (IL)-1, tumor necrosis factor (TNF)-α, and IL-6 [3-4]. AZ11657312 has been investigated as an antiinflammatory treatment for conditions such as COPD, Crohn's disease and osteo- and rheumatoid arthritis.
This compound is now included in AstaZeneca's Open Innovation Pharmacology Toolbox.
|GtoPdb PubChem SID||223366055|
|Search Google for chemical match using the InChIKey||XYNNEMHCLNODBL-UHFFFAOYSA-N|
|Search Google for chemicals with the same backbone||XYNNEMHCLNODBL|
|Search UniChem for chemical match using the InChIKey||XYNNEMHCLNODBL-UHFFFAOYSA-N|
|Search UniChem for chemicals with the same backbone||XYNNEMHCLNODBL|